fenil210/Med-Lamma huggingface dataset:
What is (are) Ovarian, Fallopian Tube, and Primary Peritoneal Cancer ?
Key Points
                    - Ovarian, fallopian tube, and primary peritoneal cancers are diseases in which malignant (cancer) cells form in the ovaries, fallopian tubes, or peritoneum.    - Ovarian cancer is the leading cause of death from cancer of the female reproductive system.
                
                
                    Ovarian, fallopian tube, and primary peritoneal cancers are diseases in which malignant (cancer) cells form in the ovaries, fallopian tubes, or peritoneum.
                    The ovaries are a pair of organs in the female reproductive system. They are in the pelvis, one on each side of the uterus (the hollow, pear-shaped organ where a fetus grows). Each ovary is about the size and shape of an almond. The ovaries make eggs and female hormones (chemicals that control the way certain cells or organs work in the body).   The fallopian tubes are a pair of long, slender tubes, one on each side of the uterus. Eggs pass from the ovaries, through the fallopian tubes, to the uterus. Cancer sometimes begins at the end of the fallopian tube near the ovary and spreads to the ovary.   The peritoneum is the tissue that lines the abdominal wall and covers organs in the abdomen. Primary peritoneal cancer is cancer that forms in the peritoneum and has not spread there from another part of the body. Cancer sometimes begins in the peritoneum and spreads to the ovary.
                
                
                    Ovarian cancer is the leading cause of death from cancer of the female reproductive system.
                    In recent years, there has been a small decrease in the number of new cases of ovarian cancer and the number of deaths from ovarian cancer. New cases of ovarian cancer and deaths from ovarian cancer are higher among white women than black women, but have decreased in both groups.   Women who have a family history of ovarian cancer and/or certain inherited gene changes, such as BRCA1 or BRCA2 gene changes, have a higher risk than women who do not have a family history or who have not inherited these gene changes. For women with inherited risk, genetic counseling and genetic testing can be used to find out more about how likely they are to develop ovarian cancer.   It is hard to find ovarian cancer early. Early ovarian cancer may not cause any symptoms. When symptoms do appear, ovarian cancer is often advanced.   See the following PDQ summaries for more information about ovarian, fallopian tube, and primary peritoneal cancers:         -  Genetics of Breast and Gynecologic Cancers (written for health professionals)    -  Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening     -  Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment + CancerGov + Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
what research (or clinical trials) is being done for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer ?
Cancer prevention clinical trials are used to study ways to prevent cancer.
                    Cancer prevention clinical trials are used to study ways to lower the risk of developing certain types of cancer. Some cancer prevention trials are conducted with healthy people who have not had cancer but who have an increased risk for cancer. Other prevention trials are conducted with people who have had cancer and are trying to prevent another cancer of the same type or to lower their chance of developing a new type of cancer. Other trials are done with healthy volunteers who are not known to have any risk factors for cancer.   The purpose of some cancer prevention clinical trials is to find out whether actions people take can prevent cancer. These may include eating fruits and vegetables, exercising, quitting smoking, or taking certain medicines, vitamins, minerals, or food supplements.
                
                
                    New ways to prevent ovarian, fallopian tube, and primary peritoneal cancer are being studied in clinical trials.
                    Clinical trials are taking place in many parts of the country. Information about clinical trials can be found in the Clinical Trials section of the NCI website. Check NCI's list of cancer clinical trials for ovarian cancer prevention trials that are now accepting patients. + CancerGov + Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
What is (are) Laryngeal Cancer ?
Key Points
                    - Laryngeal cancer is a disease in which malignant (cancer) cells form in the tissues of the larynx.    - Use of tobacco products and drinking too much alcohol can affect the risk of laryngeal cancer.    - Signs and symptoms of laryngeal cancer include a sore throat and ear pain.     - Tests that examine the throat and neck are used to help detect (find), diagnose, and stage laryngeal cancer.    - Certain factors affect prognosis (chance of recovery) and treatment options.
                
                
                    Laryngeal cancer is a disease in which malignant (cancer) cells form in the tissues of the larynx.
                    The larynx is a part of the throat, between the base of the tongue and the trachea. The larynx contains the vocal cords, which vibrate and make sound when air is directed against them. The sound echoes through the pharynx, mouth, and nose to make a person's voice.   There are three main parts of the larynx:          -  Supraglottis: The upper part of the larynx above the vocal cords, including the epiglottis.    -  Glottis: The middle part of the larynx where the vocal cords are located.    -  Subglottis: The lower part of the larynx between the vocal cords and the trachea (windpipe).         Most laryngeal cancers form in squamous cells, the thin, flat cells lining the inside of the larynx.    Laryngeal cancer is a type of head and neck cancer. + CancerGov + Laryngeal Cancer
Who is at risk for Laryngeal Cancer? ?
Use of tobacco products and drinking too much alcohol can affect the risk of laryngeal cancer.Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk with your doctor if you think you may be at risk. + CancerGov + Laryngeal Cancer
What are the symptoms of Laryngeal Cancer ?
Signs and symptoms of laryngeal cancer include a sore throat and ear pain. These and other signs and symptoms may be caused by laryngeal cancer or by other conditions. Check with your doctor if you have any of the following:         - A sore throat or cough that does not go away.    - Trouble or pain when swallowing.    - Ear pain.    - A lump in the neck or throat.    - A change or hoarseness in the voice. + CancerGov + Laryngeal Cancer
What is the outlook for Laryngeal Cancer ?
Certain factors affect prognosis (chance of recovery) and treatment options. Prognosis (chance of recovery) depends on the following:         - The stage of the disease.    - The location and size of the tumor.    - The grade of the tumor.    - The patient's age, gender, and general health, including whether the patient is anemic.         Treatment options depend on the following:         - The stage of the disease.    - The location and size of the tumor.    - Keeping the patient's ability to talk, eat, and breathe as normal as possible.    - Whether the cancer has come back (recurred).        Smoking tobacco and drinking alcohol decrease the effectiveness of treatment for laryngeal cancer. Patients with laryngeal cancer who continue to smoke and drink are less likely to be cured and more likely to develop a second tumor. After treatment for laryngeal cancer, frequent and careful follow-up is important. + CancerGov + Laryngeal Cancer
what research (or clinical trials) is being done for Laryngeal Cancer ?
New types of treatment are being tested in clinical trials.
                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI Web site.     Chemoprevention     Chemoprevention is the use of drugs, vitamins, or other substances to reduce the risk of developing cancer or to reduce the risk cancer will recur (come back). The drug isotretinoin is being studied to prevent the development of a second cancer in patients who have had cancer of the head or neck.        Radiosensitizers     Radiosensitizers are drugs that make tumor cells more sensitive to radiation therapy. Combining radiation therapy with radiosensitizers may kill more tumor cells.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials. + CancerGov + Laryngeal Cancer
What is (are) Colorectal Cancer ?
Key Points
                    - Colorectal cancer is a disease in which malignant (cancer) cells form in the tissues of the colon or the rectum.     - Colorectal cancer is the second leading cause of death from cancer in the United States.
                
                
                    Colorectal cancer is a disease in which malignant (cancer) cells form in the tissues of the colon or the rectum.
                    The colon is part of the body's digestive system. The digestive system removes and processes nutrients (vitamins, minerals, carbohydrates, fats, proteins, and water) from foods and helps pass waste material out of the body. The digestive system is made up of the mouth, throat, esophagus, stomach, and the small and large intestines. The colon (large bowel) is the first part of the large intestine and is about 5 feet long. Together, the rectum and anal canal make up the last part of the large intestine and are 6 to 8 inches long. The anal canal ends at the anus (the opening of the large intestine to the outside of the body).       Cancer that begins in the colon is called colon cancer, and cancer that begins in the rectum is called rectal cancer. Cancer that affects either of these organs may also be called colorectal cancer.   See the following PDQ summaries for more information about colorectal cancer:         -  Colorectal Cancer Screening     -  Colon Cancer Treatment     -  Rectal Cancer Treatment     -  Genetics of Colorectal Cancer
                
                
                    Colorectal cancer is the second leading cause of death from cancer in the United States.
                    The number of new colorectal cancer cases and the number of deaths from colorectal cancer are both decreasing a little bit each year. However, in adults younger than 50 years, the number of new colorectal cancer cases has slowly increased since 1998. The number of new colorectal cancers and deaths from colorectal cancer are higher in African Americans than in other races.   Finding and treating colorectal cancer early may prevent death from colorectal cancer. Screening tests may be used to help find colorectal cancer. + CancerGov + Colorectal Cancer
what research (or clinical trials) is being done for Colorectal Cancer ?
Cancer prevention clinical trials are used to study ways to prevent cancer.
                    Cancer prevention clinical trials are used to study ways to lower the risk of developing certain types of cancer. Some cancer prevention trials are conducted with healthy people who have not had cancer but who have an increased risk for cancer. Other prevention trials are conducted with people who have had cancer and are trying to prevent another cancer of the same type or to lower their chance of developing a new type of cancer. Other trials are done with healthy volunteers who are not known to have any risk factors for cancer.     The purpose of some cancer prevention clinical trials is to find out whether actions people take can prevent cancer. These may include exercising more or quitting smoking or taking certain medicines, vitamins, minerals, or food supplements.
                
                
                    New ways to prevent colorectal cancer are being studied in clinical trials.
                    Clinical trials are taking place in many parts of the country. Information about clinical trials can be found in the Clinical Trials section of the NCI website. Check NCI's list of cancer clinical trials for colon cancer prevention trials or rectal cancer prevention trials that are now accepting patients. + CancerGov + Colorectal Cancer
Who is at risk for Plasma Cell Neoplasms (Including Multiple Myeloma)? ?
Age can affect the risk of plasma cell neoplasms. Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk with your doctor if you think you may be at risk.    Plasma cell neoplasms are most common in people who are middle aged or older. For multiple myeloma and plasmacytoma, other risk factors include the following:          - Being black.    - Being male.    - Having a personal history of MGUS or plasmacytoma.    - Being exposed to radiation or certain chemicals. + CancerGov + Plasma Cell Neoplasms (Including Multiple Myeloma)
What is the outlook for Plasma Cell Neoplasms (Including Multiple Myeloma) ?
Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) depends on the following:         - The type of plasma cell neoplasm.    - The stage of the disease.    - Whether a certain immunoglobulin (antibody) is present.    - Whether there are certain genetic changes.    - Whether the kidney is damaged.    - Whether the cancer responds to initial treatment or recurs (comes back).        Treatment options depend on the following:         - The type of plasma cell neoplasm.    - The age and general health of the patient.    - Whether there are signs, symptoms, or health problems, such as kidney failure or infection, related to the disease.    - Whether the cancer responds to initial treatment or recurs (comes back). + CancerGov + Plasma Cell Neoplasms (Including Multiple Myeloma)
What is (are) Salivary Gland Cancer ?
Key Points
                    - Salivary gland cancer is a rare disease in which malignant (cancer) cells form in the tissues of the salivary glands.    - Being exposed to certain types of radiation may increase the risk of salivary cancer.     - Signs of salivary gland cancer include a lump or trouble swallowing.     - Tests that examine the head, neck, and the inside of the mouth are used to detect (find) and diagnose salivary gland cancer.    - Certain factors affect treatment options and prognosis (chance of recovery).
                
                
                    Salivary gland cancer is a rare disease in which malignant (cancer) cells form in the tissues of the salivary glands.
                    The salivary glands make saliva and release it into the mouth. Saliva has enzymes that help digest food and antibodies that help protect against infections of the mouth and throat. There are 3 pairs of major salivary glands:         - Parotid glands: These are the largest salivary glands and are found in front of and just below each ear. Most major salivary gland tumors begin in this gland.    - Sublingual glands: These glands are found under the tongue in the floor of the mouth.    - Submandibular glands: These glands are found below the jawbone.         There are also hundreds of small (minor) salivary glands lining parts of the mouth, nose, and larynx that can be seen only with a microscope. Most small salivary gland tumors begin in the palate (roof of the mouth).   More than half of all salivary gland tumors are benign (not cancerous) and do not spread to other tissues.     Salivary gland cancer is a type of head and neck cancer. + CancerGov + Salivary Gland Cancer
Who is at risk for Salivary Gland Cancer? ?
Being exposed to certain types of radiation may increase the risk of salivary cancer. Anything that increases the chance of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesnt mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Although the cause of most salivary gland cancers is not known, risk factors include the following:         - Older age.    - Treatment with radiation therapy to the head and neck.    - Being exposed to certain substances at work. + CancerGov + Salivary Gland Cancer
What are the symptoms of Salivary Gland Cancer ?
Signs of salivary gland cancer include a lump or trouble swallowing. Salivary gland cancer may not cause any symptoms. It may be found during a regular dental check-up or physical exam. Signs and symptoms may be caused by salivary gland cancer or by other conditions. Check with your doctor if you have any of the following:         - A lump (usually painless) in the area of the ear, cheek, jaw, lip, or inside the mouth.    -  Fluid draining from the ear.    - Trouble swallowing or opening the mouth widely.    - Numbness or weakness in the face.    - Pain in the face that does not go away. + CancerGov + Salivary Gland Cancer
How to diagnose Salivary Gland Cancer ?
Tests that examine the head, neck, and the inside of the mouth are used to detect (find) and diagnose salivary gland cancer. The following procedures may be used:         -  Physical exam and history : An exam of the body to check general signs of health. The head, neck, mouth, and throat will be checked for signs of disease, such as lumps or anything else that seems unusual. A history of the patient's health habits and past illnesses and treatments will also be taken.    -   MRI (magnetic resonance imaging): A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of areas inside the body. This procedure is also called nuclear magnetic resonance imaging (NMRI).    -   CT scan (CAT scan): A procedure that makes a series of detailed pictures of areas inside the body, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.     -   PET scan (positron emission tomography scan): A procedure to find malignant tumor cells in the body. A small amount of radioactive glucose (sugar) is injected into a vein. The PET scanner rotates around the body and makes a picture of where glucose is being used in the body. Malignant tumor cells show up brighter in the picture because they are more active and take up more glucose than normal cells do.    -   Endoscopy : A procedure to look at organs and tissues inside the body to check for abnormal areas. For salivary gland cancer, an endoscope is inserted into the mouth to look at the mouth, throat, and larynx. An endoscope is a thin, tube-like instrument with a light and a lens for viewing.     -   Biopsy : The removal of cells or tissues so they can be viewed under a microscope by a pathologist to check for signs of cancer.               -  Fine needle aspiration (FNA) biopsy : The removal of tissue or fluid using a thin needle. An FNA is the most common type of biopsy used for salivary gland cancer.      -  Incisional biopsy : The removal of part of a lump or a sample of tissue that doesnt look normal.      -  Surgery : If cancer cannot be diagnosed from the sample of tissue removed during an FNA biopsy or an incisional biopsy, the mass may be removed and checked for signs of cancer.                 Because salivary gland cancer can be hard to diagnose, patients should ask to have the tissue samples checked by a pathologist who has experience in diagnosing salivary gland cancer. + CancerGov + Salivary Gland Cancer
What is the outlook for Salivary Gland Cancer ?
Certain factors affect treatment options and prognosis (chance of recovery). The treatment options and prognosis (chance of recovery) depend on the following:         - The stage of the cancer (especially the size of the tumor).    - The type of salivary gland the cancer is in.    - The type of cancer cells (how they look under a microscope).    - The patient's age and general health. + CancerGov + Salivary Gland Cancer
what research (or clinical trials) is being done for Salivary Gland Cancer ?
New types of treatment are being tested in clinical trials.
                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.     Radiosensitizers     Radiosensitizers are drugs that make tumor cells more sensitive to radiation therapy. Combining radiation therapy with radiosensitizers may kill more tumor cells.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials. + CancerGov + Salivary Gland Cancer